Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

994 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Standardizing radiation dose reporting in the pediatric cardiac catheterization laboratory-a multicenter study by the CCISC (Congenital Cardiovascular Interventional Study Consortium).
Kobayashi D, Meadows J, Forbes TJ, Moore P, Javois AJ, Pedra CA, Du W, Gruenstein DH, Wax DF, Hill JA, Graziano JN, Fagan TE, Alvarez WM, Nykanen DG, Divekar AA. Kobayashi D, et al. Among authors: hill ja. Catheter Cardiovasc Interv. 2014 Nov 1;84(5):785-93. doi: 10.1002/ccd.25467. Epub 2014 Mar 18. Catheter Cardiovasc Interv. 2014. PMID: 24585540
Proteomics FASTA archive and reference resource.
Falkner JA, Hill JA, Andrews PC. Falkner JA, et al. Among authors: hill ja. Proteomics. 2008 May;8(9):1756-7. doi: 10.1002/pmic.200701194. Proteomics. 2008. PMID: 18442177 Free article.
Tranche distributed repository and ProteomeCommons.org.
Smith BE, Hill JA, Gjukich MA, Andrews PC. Smith BE, et al. Among authors: hill ja. Methods Mol Biol. 2011;696:123-45. doi: 10.1007/978-1-60761-987-1_8. Methods Mol Biol. 2011. PMID: 21063945
Development and validation of predictive models of early immune effector cell-associated hematotoxicity (eIPMs).
Liang EC, Huang JJ, Portuguese AJ, Ortiz-Maldonado V, Albittar A, Wuliji N, Basom R, Jeon Y, Wu QV, Torkelson A, Kirchmeier DR, Chutnik A, Pender BS, Sorror ML, Hill JA, Kopmar NE, Banerjee R, Cowan AJ, Green DJ, Gopal AK, Poh C, Shadman M, Hirayama AV, Till BG, Kimble EL, Iovino L, Chapuis AG, Otegbeye F, Cassaday RD, Milano F, Turtle CJ, Maloney DG, Gauthier J. Liang EC, et al. Among authors: hill ja. Blood Adv. 2024 Dec 3:bloodadvances.2024014455. doi: 10.1182/bloodadvances.2024014455. Online ahead of print. Blood Adv. 2024. PMID: 39626349
Off-the-shelf allogeneic natural killer cells for the treatment of COVID-19.
Liu WL, Kampouri E, Bui JK, Sekhon MK, Tercero A, Finlay D, Asghedom LH, Romasanta GR, Rice NT, Ranjbaran F, Stoltzman C, Cook J, Blake J, Delaney CS, Hill JA. Liu WL, et al. Among authors: hill ja. Mol Ther Methods Clin Dev. 2024 Oct 28;32(4):101361. doi: 10.1016/j.omtm.2024.101361. eCollection 2024 Dec 12. Mol Ther Methods Clin Dev. 2024. PMID: 39624798 Free PMC article.
Association of CD19+-targeted chimeric antigen receptor (CAR) T-cell therapy with hypogammaglobulinemia, infection, and mortality.
Sutherland NM, Zhou B, Zhang L, Ong MS, Hong JS, Pak A, Liu KJ, Frigault MJ, Maus MV, Hill JA, Reynolds K, Walter JE, Camargo CA Jr, Barmettler S. Sutherland NM, et al. Among authors: hill ja. J Allergy Clin Immunol. 2024 Nov 4:S0091-6749(24)01165-5. doi: 10.1016/j.jaci.2024.10.021. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 39505278
994 results